| pubmed-article:9772310 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9772310 | lifeskim:mentions | umls-concept:C1321605 | lld:lifeskim |
| pubmed-article:9772310 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:9772310 | lifeskim:mentions | umls-concept:C0041469 | lld:lifeskim |
| pubmed-article:9772310 | lifeskim:mentions | umls-concept:C0875949 | lld:lifeskim |
| pubmed-article:9772310 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:9772310 | lifeskim:mentions | umls-concept:C0724375 | lld:lifeskim |
| pubmed-article:9772310 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9772310 | pubmed:dateCreated | 1999-1-21 | lld:pubmed |
| pubmed-article:9772310 | pubmed:abstractText | Several live attenuated vaccines against bacterial enteric pathogens have recently been licensed. These include the Salmonella typhi Ty21a typhoid vaccine (Vivotif Berna(R) Vaccine) and Vibrio cholerae CVD103-HgR cholera vaccine (Mutacol Berna(R) Vaccine). They comprise a unique class of biologics in which patient compliance is required for their optimal use. This is of particular importance in the case of the Ty21a vaccine strain of which multiple doses are required. Furthermore, exposure to heat, concomitant use with antibiotics or antimalarial drugs, and timing of vaccination with respect to food intake can affect vaccine potency and/or efficacy. This study was conducted to determine the level of compliance among adult North American travelers and to evaluate compliance errors with respect to potential vaccine efficacy. | lld:pubmed |
| pubmed-article:9772310 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9772310 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9772310 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9772310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9772310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9772310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9772310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9772310 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9772310 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9772310 | pubmed:issn | 1195-1982 | lld:pubmed |
| pubmed-article:9772310 | pubmed:author | pubmed-author:CryzS JSJJr | lld:pubmed |
| pubmed-article:9772310 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9772310 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:9772310 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9772310 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9772310 | pubmed:pagination | 14-7 | lld:pubmed |
| pubmed-article:9772310 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:meshHeading | pubmed-meshheading:9772310-... | lld:pubmed |
| pubmed-article:9772310 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9772310 | pubmed:articleTitle | Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a. | lld:pubmed |
| pubmed-article:9772310 | pubmed:affiliation | Swiss Serum and Vaccine Institute, Rehhagstrasse 79, CH-3018, Bern, Switzerland. | lld:pubmed |
| pubmed-article:9772310 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9772310 | lld:pubmed |
